Improved late survival and disability after stroke with therapeutic anticoagulation for atrial fibrillation: A population study

Stroke

Volumn 42, Issue 9, 2011, Pages 2503-2508

  Hannon, Niamh ^a   Callaly, Elizabeth ^a   Moore, Alan ^c   Ní Chróinín, Danielle ^a   Sheehan, Órla ^a   Marnane, Michael ^a   Merwick, Áine ^a   Kyne, Lorraine ^a   Duggan, Joseph ^a   McCormack, Patricia M E ^d   Dolan, Eamon ^d   Crispino O'Connell, Gloria ^b   Harris, Dawn ^a   Horgan, Gillian ^a   Williams, David ^c   Kelly, Peter J ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c BEAUMONT HOSPITAL   (Ireland)

^d Royal College of Surgeons in Ireland   (Ireland)

Author keywords

anticoagulation; atrial fibrillation; stroke prevention

Indexed keywords

ANTITHROMBOCYTIC AGENT; WARFARIN;

AGED; ANTICOAGULATION; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DISABILITY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANKIN SCALE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONAL NORMALIZED RATIO; IRELAND; MALE; PROSPECTIVE STUDIES; STROKE; SURVIVAL RATE; TIME FACTORS; WARFARIN;

EID: 80052419702     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.602235     Document Type: Article

References (18)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-988.
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med. 1987; 147:1561-1564.
3. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial fibrillation (ATRIA) study. J Am Med Assoc. 2001;285:2370-2375.
4. Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke. 2005;36: 1115-1119.
5. Hannon N, Sheehan O, Kelly L, Marnane M, Merwick A, Moore A, et al. Stroke associated with atrial fibrillation: incidence and early outcomes in the North Dublin Population Stroke Study. Cerebrovasc Dis. 2010;29: 43-49.
6. Mattle HP. Long-term outcome after stroke due to atrial fibrillation. Cerebrovasc Dis. 2003;16:3-8.
7. Boccuzzi SJ, Martin J, Stephenson J, Kreilick C, Fernandes J, Beaulieu J, et al. Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed. Curr Med Res Opin. 2009;25: 2853-2864.
8. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857-867.
9. Hylek EM, Go AS, Chang Y, Jensvold N, Henault L, Selby J, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med. 2003;349:1019-1026.
10. Indredavik B, Rohweder G, Lydersen S. Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation. J Intern Med. 2005;258:133-144.
11. O'Donnell M, Oczkowski W, Fang J, Kearon C, Silva J, Bradley C, et al, on behalf of the Investigators of the Registry of the Canadian Stroke Network. Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study. Lancet Neurol. 2006;5:749-754.
12. Schwammenthal Y, Bornstein N, Schwammenthal E, Schwartz R, Goldbourt U, Tsabari R, et al. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]). Am J Cardiol. 2010;105: 411-416.
13. Audebert HJ, Schenk B, Schenkel J, Heuschmann PU. Impact of prestroke oral anticoagulation on severity and outcome of ischemic stroke in patients with atrial fibrillation. Cerebrovasc Dis. 2010;29: 476-483.
14. Central Statistics Office Ireland 2007. Census of population of Ireland 2006, volumes 1 and 2. Dublin: Stationery Office.
15. Feigin VL, Carter K. Stroke incidence studies one step closer to the elusive gold standard? Stroke. 2004;35:2045-2047.
16. Ay H, Arsava EM, Gungor L, Greer D, Singhal AB, Furie KL, et al. Admission International Normalized Ratio and acute infarct volume in ischemic stroke. Ann Neurol. 2008;64:499-506.
17. Paciaroni M, Agnelli G, Caso V, Venti M, Milia P, Sivestrellli G, et al. Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome. J Thromb Haemost. 2005;3:1218-1223.
18. Gladstone DJ, Bui E, Fang J, Laupacis A, Lindsay MP, Tu JV, et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke. 2009;40:235-240.